80 related articles for article (PubMed ID: 26591586)
1. [MIMICKING ISCHEMIC PRECONDITIONING PHENOMENON THROUGH THE IMPACT ON THE CANNABINOID RECEPTORS: ROLE OF PROTEIN KINASE AND NO-SYNTHASE].
Lishmanov YB; Maslov LN; Krylatov AV; Khaliulin IG
Ross Fiziol Zh Im I M Sechenova; 2015 Aug; 101(8):909-20. PubMed ID: 26591586
[TBL] [Abstract][Full Text] [Related]
2. [Mediated role of NO-syntase, protein kinase C and KATP-channels in realization of cardioprotective impact of cannabinoid HU-210].
Maslov LN; Lasukova OV; Krylatov AV; Khanush L; Lishmanov IuB
Eksp Klin Farmakol; 2012; 75(12):15-8. PubMed ID: 23700661
[TBL] [Abstract][Full Text] [Related]
3. Prospects for Creation of Cardioprotective Drugs Based on Cannabinoid Receptor Agonists.
Maslov LN; Khaliulin I; Zhang Y; Krylatov AV; Naryzhnaya NV; Mechoulam R; De Petrocellis L; Downey JM
J Cardiovasc Pharmacol Ther; 2016 May; 21(3):262-72. PubMed ID: 26487546
[TBL] [Abstract][Full Text] [Related]
4. Activation of type II cannabinoid receptors improves myocardial tolerance to arrhythmogenic effects of coronary occlusion and reperfusion.
Krylatov AV; Ugdyzhekova DS; Bernatskaya NA; Maslov LN; Mekhoulam R; Pertwee RG; Stephano GB
Bull Exp Biol Med; 2001 Jun; 131(6):523-5. PubMed ID: 11586395
[TBL] [Abstract][Full Text] [Related]
5. [Alterations of inotropic function of isolated heart and extent of injury of cardiomyocytes after cannabinoid receptor activation during ischemia and reperfusion].
Maslov LN; Lasukova OV; Krylatov AV; Lishmanov IuB; Pertwee R
Ross Fiziol Zh Im I M Sechenova; 2003 Sep; 89(9):1108-16. PubMed ID: 14758634
[TBL] [Abstract][Full Text] [Related]
6. [Role of cannabinoid receptors in regulation of cardiac tolerance to ischemia and reperfusion].
Lasukova OV; Maslov LN; Ermakov SIu; Crawford D; Barth F; Krylatov AV; Hanus LO
Izv Akad Nauk Ser Biol; 2008; (4):471-8. PubMed ID: 18771032
[TBL] [Abstract][Full Text] [Related]
7. [Increase of the heart arrhythmogenic resistance and decrease of the myocardial necrosis zone during activation of cannabinoid receptors].
Krylatov AV; Bernatskaia NA; Maslov LN; Pertwee RG; Mechoulam R; Stefano GB; Sharaevskiĭ MA; Sal'nikova OM
Ross Fiziol Zh Im I M Sechenova; 2002 May; 88(5):560-7. PubMed ID: 12136723
[TBL] [Abstract][Full Text] [Related]
8. Role of cyclic nucleotides and NO synthase in mechanisms of cardioprotective effects of cannabinoid HU-210.
Maslov LN; Krylatov AV; Lishmanov YB
Bull Exp Biol Med; 2014 Sep; 157(5):588-91. PubMed ID: 25257420
[TBL] [Abstract][Full Text] [Related]
9. [Antiarrhythmic properties of a cannabinoid (CB) receptor agonist].
Maslov LN; Lishmanov IuB; Maĭsmekulova LA; Mechoulam P
Eksp Klin Farmakol; 2001; 64(3):37-40. PubMed ID: 11558437
[TBL] [Abstract][Full Text] [Related]
10. Activation of peripheral delta2 opioid receptors increases cardiac tolerance to ischemia/reperfusion injury Involvement of protein kinase C, NO-synthase, KATP channels and the autonomic nervous system.
Maslov LN; Lishmanov YB; Oeltgen PR; Barzakh EI; Krylatov AV; Govindaswami M; Brown SA
Life Sci; 2009 May; 84(19-20):657-63. PubMed ID: 19245818
[TBL] [Abstract][Full Text] [Related]
11. [Paticipation of cannabinoid receptors in the regulation of cardiac rhythm and cardiac contractility].
Maslov LN; Ermakov SIu; Lasukova OV; Barzakh EI; Krylatov AV; Crawford D; Serebrov VIu
Ross Fiziol Zh Im I M Sechenova; 2006 Apr; 92(4):429-39. PubMed ID: 16813149
[TBL] [Abstract][Full Text] [Related]
12. 2-Arachidonylglycerol acting on CB1 cannabinoid receptors mediates delayed cardioprotection induced by nitric oxide in rat isolated hearts.
Wagner JA; Abesser M; Harvey-White J; Ertl G
J Cardiovasc Pharmacol; 2006 May; 47(5):650-5. PubMed ID: 16775503
[TBL] [Abstract][Full Text] [Related]
13. Synthetic and endogenous cannabinoids protect retinal neurons from AMPA excitotoxicity in vivo, via activation of CB1 receptors: Involvement of PI3K/Akt and MEK/ERK signaling pathways.
Kokona D; Thermos K
Exp Eye Res; 2015 Jul; 136():45-58. PubMed ID: 25989217
[TBL] [Abstract][Full Text] [Related]
14. Endogenous cannabinoids contribute to remote ischemic preconditioning via cannabinoid CB2 receptors in the rat heart.
Hajrasouliha AR; Tavakoli S; Ghasemi M; Jabehdar-Maralani P; Sadeghipour H; Ebrahimi F; Dehpour AR
Eur J Pharmacol; 2008 Jan; 579(1-3):246-52. PubMed ID: 17950273
[TBL] [Abstract][Full Text] [Related]
15. CB-Receptor Agonist HU-210 Mimics the Postconditioning Phenomenon of Isolated Heart.
Gorbunov AS; Maslov LN; Tsibulnikov SY; Khaliulin IG; Tsepokina AV; Khutornaya MV; Kutikhin AG
Bull Exp Biol Med; 2016 Nov; 162(1):27-29. PubMed ID: 27878734
[TBL] [Abstract][Full Text] [Related]
16. Acute activation of CB1 cannabinoid receptors transiently decreases PSA-NCAM expression in the dentate gyrus of the rat hippocampus.
Maćkowiak M; Chocyk A; Markowicz-Kula K; Wedzony K
Brain Res; 2007 May; 1148():43-52. PubMed ID: 17355876
[TBL] [Abstract][Full Text] [Related]
17. Sevoflurane enhances ethanol-induced cardiac preconditioning through modulation of protein kinase C, mitochondrial KATP channels, and nitric oxide synthase, in guinea pig hearts.
Kaneda K; Miyamae M; Sugioka S; Okusa C; Inamura Y; Domae N; Kotani J; Figueredo VM
Anesth Analg; 2008 Jan; 106(1):9-16, table of contents. PubMed ID: 18165545
[TBL] [Abstract][Full Text] [Related]
18. [Preconditioning impact on coronary perfusion during ischemia and reperfusion of heart].
Maslov LN; Lishmanov IuB; Oeltgen P; Peĭ JM; Krylatov AV; Barzakh EI; Portnichenko AG; Meshoulam R
Ross Fiziol Zh Im I M Sechenova; 2012 Apr; 98(4):433-48. PubMed ID: 22834333
[TBL] [Abstract][Full Text] [Related]
19. Differential modulations of striatal tyrosine hydroxylase and dopamine metabolism by cannabinoid agonists as evidence for functional selectivity in vivo.
Bosier B; Muccioli GG; Mertens B; Sarre S; Michotte Y; Lambert DM; Hermans E
Neuropharmacology; 2012 Jun; 62(7):2328-36. PubMed ID: 22365976
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of anxiety-like responsiveness to the cannabinoid CB(1) receptor agonist HU-210 following chronic stress.
Hill MN; Gorzalka BB
Eur J Pharmacol; 2004 Sep; 499(3):291-5. PubMed ID: 15381051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
